Dabur India Ltd
NSE:DABUR
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
451.4
552.7
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Dabur India Ltd
Dabur India Ltd., rooted deeply in the rich tapestry of ancient Ayurvedic traditions, has organically evolved into one of India's leading FMCG companies. Established in the late 19th century by Dr. S.K. Burman, Dabur began its journey with a mission to provide effective and affordable healthcare solutions. Over the years, the company has skillfully blended age-old wisdom with modern scientific research to craft a diverse product portfolio ranging from personal care products, health supplements, and digestives to over-the-counter medications and foods. This unique approach harnessing the virtues of natural ingredients has not only won consumer trust but also solidified Dabur's standing as a pioneer in herbal and natural products.
The engine that drives Dabur’s financial performance is its expansive product range, complemented by an extensive distribution network that spans both urban and rural India. By strategically tapping into various sectors such as health care, personal care, and foods, Dabur has effectively spread its revenue streams, reducing dependency on any single category. With flagship brands like Dabur Chyawanprash, Dabur Honey, Vatika, and Real, the company enjoys strong brand equity. It continuously invests in marketing and innovation to expand its reach and engage a broader audience. Additionally, its export operations cater to the global demand for natural and holistic products, further bolstering revenue. Dabur's ability to adapt and innovate while staying true to its natural-centric philosophy ensures its robust presence in both domestic and international markets.
Dabur India Ltd., rooted deeply in the rich tapestry of ancient Ayurvedic traditions, has organically evolved into one of India's leading FMCG companies. Established in the late 19th century by Dr. S.K. Burman, Dabur began its journey with a mission to provide effective and affordable healthcare solutions. Over the years, the company has skillfully blended age-old wisdom with modern scientific research to craft a diverse product portfolio ranging from personal care products, health supplements, and digestives to over-the-counter medications and foods. This unique approach harnessing the virtues of natural ingredients has not only won consumer trust but also solidified Dabur's standing as a pioneer in herbal and natural products.
The engine that drives Dabur’s financial performance is its expansive product range, complemented by an extensive distribution network that spans both urban and rural India. By strategically tapping into various sectors such as health care, personal care, and foods, Dabur has effectively spread its revenue streams, reducing dependency on any single category. With flagship brands like Dabur Chyawanprash, Dabur Honey, Vatika, and Real, the company enjoys strong brand equity. It continuously invests in marketing and innovation to expand its reach and engage a broader audience. Additionally, its export operations cater to the global demand for natural and holistic products, further bolstering revenue. Dabur's ability to adapt and innovate while staying true to its natural-centric philosophy ensures its robust presence in both domestic and international markets.
Revenue growth: Dabur reported consolidated revenue growth of 5.4% YoY in Q2, with India FMCG up 5.7% and international business up 7.7% in INR terms.
GST impact: A recent GST rate cut affected almost two-thirds of Dabur's portfolio, leading to short-term sales disruption (3–4% volume impact), but management expects it to be a long-term positive for consumer demand.
Profitability: Operating profit grew 6.4% and PAT rose 6.5% YoY, both ahead of top-line growth, aided by cost-saving initiatives and price increases.
Segment highlights: Toothpaste, Hair Oils, and Honey saw strong growth and market share gains, with Juices and Nectars challenged by weather but premium products outperforming.
Guidance: Management guides for mid- to high-single digit growth in H2, backed by low- to mid-single digit volume growth, and expects margins for the full year to improve over sales growth.
Strategic move: Launch of Dabur Ventures with INR 500 crore to invest in digital-first brands, aiming for innovation-led and premiumization-driven growth.